Elon Musk’s brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the US Food and Drug Administration’s “breakthrough device” designation.
Related Posts
iPhone 16 Available With Decent Discounts and Bank Offers During Christmas Carnival Sale
iPhone 16 was launched globally in September at a starting price of Rs. 79,900, however, Apple’s exclusive retail store Imagine is offering the smartphone with […]
EU’s ESMA Sets Deadline for Crypto Service Providers to Restrict Non MiCA-Compliant Stablecoins
- staff
- January 21, 2025
- 0
The European Securities and Markets Authority (ESMA) of the EU has asked crypto-asset service providers (CASPs) to put such procedures in place that can assess […]
iPhone 16 Series Sales Match Apple’s Expectations, Low Demand for Base Models: Kuo
iPhone 16 series was launched by Apple at a special event held in September at Apple Park in California. The latest smartphone lineup from the […]